Adaptimmune announced the closing of its initial public offering of 11,250,000 American Depositary Shares at a price to the public of $17.00 per ADS. Read the full story

Spark Therapeutics has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission Read the full story

Carbylan Therapeutics, which is developing a novel, injectable treatment for osteoarthritis pain, filed with the SEC to raise up to $86 million Read the full story

TRACON Pharmaceuticals, which is developing antibodies to treat cancer, AMD and fibrotic diseases, filed with the SEC to raise up to $58 million Read the full story

Asante Solutions has filed to raise up to $45 million in an IPO financing to help it further commercialize its insulin pump, which is designed to be easy to use and is cheaper than products by major competitors. Read the full story

Juno Therapeutics announced the pricing of its initial public offering of 11,022,917 shares of common stock at a price to the public of $24.00 per share Read the full story

Medovex has priced its initial public offering of 1,391,305 units, each unit consisting of one share of common stock and one Series A Warrant, at a price to the public of $5.75 per unit Read the full story

Ascendis Pharma will go public, raising up to $86 million towards an IPO Read the full story

Second Sight Medical Products secured it pricing of its initial public offering of 3,500,000 shares of common stock, at a price of $9.00 per share Read the full story